Ogunwobi OO - Search Results

1

Intrahepatic cholangiocarcinoma progression: prognostic factors and basic mechanisms.

Sirica AE, Dumur CI, Campbell DJ, Almenara JA, Ogunwobi OO, Dewitt JL. Sirica AE, et al. Among authors: ogunwobi oo. Clin Gastroenterol Hepatol. 2009 Nov;7(11 Suppl):S68-78. doi: 10.1016/j.cgh.2009.08.023. Clin Gastroenterol Hepatol. 2009. PMID: 19896103 Free PMC article. Review.

2

Mechanisms of hepatocellular carcinoma progression.

Ogunwobi OO, Harricharran T, Huaman J, Galuza A, Odumuwagun O, Tan Y, Ma GX, Nguyen MT. Ogunwobi OO, et al. World J Gastroenterol. 2019 May 21;25(19):2279-2293. doi: 10.3748/wjg.v25.i19.2279. World J Gastroenterol. 2019. PMID: 31148900 Free PMC article. Review.

3

Therapeutic and prognostic importance of epithelial-mesenchymal transition in liver cancers: insights from experimental models.

Ogunwobi OO, Liu C. Ogunwobi OO, et al. Crit Rev Oncol Hematol. 2012 Sep;83(3):319-28. doi: 10.1016/j.critrevonc.2011.11.007. Epub 2011 Dec 16. Crit Rev Oncol Hematol. 2012. PMID: 22178416 Review.

4

Cyclooxygenase-2 and Akt mediate multiple growth-factor-induced epithelial-mesenchymal transition in human hepatocellular carcinoma.

Ogunwobi OO, Wang T, Zhang L, Liu C. Ogunwobi OO, et al. J Gastroenterol Hepatol. 2012 Mar;27(3):566-78. doi: 10.1111/j.1440-1746.2011.06980.x. J Gastroenterol Hepatol. 2012. PMID: 22097969 Free PMC article.

5

miRNAs associated with prostate cancer risk and progression.

Luu HN, Lin HY, Sørensen KD, Ogunwobi OO, Kumar N, Chornokur G, Phelan C, Jones D, Kidd L, Batra J, Yamoah K, Berglund A, Rounbehler RJ, Yang M, Lee SH, Kang N, Kim SJ, Park JY, Di Pietro G. Luu HN, et al. Among authors: ogunwobi oo. BMC Urol. 2017 Mar 20;17(1):18. doi: 10.1186/s12894-017-0206-6. BMC Urol. 2017. PMID: 28320379 Free PMC article. Review.

6

Emergence of neural regulatory mechanisms in carcinogenesis.

Harricharran T, Ogunwobi OO. Harricharran T, et al. Among authors: ogunwobi oo. World J Clin Oncol. 2019 Aug 24;10(8):279-282. doi: 10.5306/wjco.v10.i8.279. World J Clin Oncol. 2019. PMID: 31528543 Free PMC article.

7

Oxytocin receptor genetic alterations in hepatocellular carcinoma.

Harricharran T, Ogunwobi OO. Harricharran T, et al. Among authors: ogunwobi oo. SN Compr Clin Med. 2019 Jul;1(7):523-526. doi: 10.1007/s42399-019-00085-2. Epub 2019 Jun 14. SN Compr Clin Med. 2019. PMID: 32856014 Free PMC article.

8

Fibronectin Regulation of Integrin B1 and SLUG in Circulating Tumor Cells.

Huaman J, Naidoo M, Zang X, Ogunwobi OO. Huaman J, et al. Among authors: ogunwobi oo. Cells. 2019 Jun 20;8(6):618. doi: 10.3390/cells8060618. Cells. 2019. PMID: 31226820 Free PMC article.

9

Circulating Tumor Cell Migration Requires Fibronectin Acting through Integrin B1 or SLUG.

Huaman J, Ogunwobi OO. Huaman J, et al. Among authors: ogunwobi oo. Cells. 2020 Jul 1;9(7):1594. doi: 10.3390/cells9071594. Cells. 2020. PMID: 32630254 Free PMC article.

10

Oxytocin and oxytocin receptor alterations, decreased survival, and increased chemoresistance in patients with pancreatic cancer.

Harricharran T, Ogunwobi OO. Harricharran T, et al. Among authors: ogunwobi oo. Hepatobiliary Pancreat Dis Int. 2020 Apr;19(2):175-180. doi: 10.1016/j.hbpd.2019.12.002. Epub 2019 Dec 14. Hepatobiliary Pancreat Dis Int. 2020. PMID: 31919036 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

72 results

Search Page